|
PWWP2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.73439999993231E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.10839999692914E-08 |
| Normal-vs-Stage2 |
6.343700E-03 |
| Normal-vs-Stage3 |
6.282300E-03 |
| Normal-vs-Stage4 |
6.961600E-01 |
| Stage1-vs-Stage2 |
6.861200E-01 |
| Stage1-vs-Stage3 |
2.556400E-01 |
| Stage1-vs-Stage4 |
3.095000E-01 |
| Stage2-vs-Stage3 |
6.155200E-01 |
| Stage2-vs-Stage4 |
3.512200E-01 |
| Stage3-vs-Stage4 |
4.040600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.52130000003115E-06 |
| Normal-vs-AfricanAmerican |
7.56630000000591E-05 |
| Normal-vs-Asian |
2.195800E-01 |
| Caucasian-vs-AfricanAmerican |
7.943200E-01 |
| Caucasian-vs-Asian |
5.528000E-01 |
| AfricanAmerican-vs-Asian |
4.116800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.26639999989509E-07 |
| Normal-vs-Female |
5.360500E-03 |
| Male-vs-Female |
4.104400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.988570E-01 |
| Normal-vs-Extreme_Weight |
1.80170000030344E-07 |
| Normal-vs-Obese |
7.66340000000199E-05 |
| Normal-vs-Extreme_Obese |
5.57409999999425E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.924400E-01 |
| Normal_Weight-vs-Obese |
4.985000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.683020E-01 |
| Extreme_Weight-vs-Obese |
4.326000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.364200E-01 |
| Obese-vs-Extreme_Obese |
3.397800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.724000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.170040E-02 |
| Normal-vs-Age(61-80Yrs) |
5.73479996823778E-09 |
| Normal-vs-Age(81-100Yrs) |
5.61000000000034E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.555200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.684570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.169230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.096150E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.636100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.641800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.26789995064303E-09 |
| Normal-VS-Type2 PRCC |
5.209700E-02 |
| Normal-VS-KIRP CIMP |
6.24639999999843E-05 |
| Normal-VS-Unclassified PRCC |
1.451650E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.204000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.610000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.730000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.151150E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.225400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.300200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56571999999633E-05 |
| Normal-vs-N1 |
8.988000E-01 |
| Normal-vs-N2 |
1.360390E-01 |
| N0-vs-N1 |
1.421180E-01 |
| N0-vs-N2 |
5.379200E-01 |
| N1-vs-N2 |
3.990000E-01 |
|
|
